BRIEF-Exicure Partners With GPCR Therapeutics To Fuel New Growth In Biotech
ReutersDec 27, 2024 1:12 AM
Dec 26 (Reuters) - Exicure Inc XCUR.O:
EXICURE, INC. PARTNERS WITH GPCR THERAPEUTICS TO FUEL NEW GROWTH IN BIOTECH
Source text: ID:nBw1xXcfda
Further company coverage: XCUR.O
((reuters.briefs@thomsonreuters.com;))
Disclaimer: For information purposes only. Past performance is not indicative of future results.
Related Articles
5 Top Semiconductor Stocks to Watch in 2025
TradingKey - The semiconductor industry is the backbone of modern technology, driving innovations in artificial intelligence (AI), cloud computing, gaming, and more.TradingKey
16 hours ago
Why Is SoFi Technologies Stock Up Over 140% in the Second Half of 2024?
TradingKey - During the Covid-19 pandemic, many investors were drawn into the growth prospects of financial technology, or fintech companies. Many of these promised to do things better, and faster, than banks.TradingKey
16 hours ago
The Best S&P 500 Index Stocks This Year: Can They Outperform Again in 2025?
TradingKey - As the year 2024 comes to a close, the S&P 500 Index has delivered an astonishing 27% return, surpassing expectations and continuing its impressive rally from the previous year.TradingKey
16 hours ago
Bitcoin Outlook 2025: Is It Time to Go “All In” Or Be Wary?
TradingKey - The cryptocurrency markets have been a hot commodity for investors over the past year. While there have always been a host of crypto coins out there, the big one that everyone talks about is Bitcoin.TradingKey
Thu, Dec 26
Quantitative Exchange Rate Forecasts
Today, we delve further into the exchange rate markets with a quantitative analysis. Our quantitative exchange rate forecasting tool is based on econometric multi-factor regression models. This approach involves identifying and analysing the key factors that influence exchange rates.Tradingkey Quant Club
Tue, Dec 24
